Form 4 for BMY Bristol Myers Squibb
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-02 · accession 0000014272-23-000195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-02 | BMY | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +616 | 7,200 | +9% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Plenge Robert M | EVP, Chief Research Off | F - Tax | $50.10 | -274 | 6,926 | -4% | -$13.7K |
| D | 2023-12-05 | 2023-12-02 | BMY | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | -616 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-12-02 | M | A | 616 | $0.00 | 7,200 | D | — | — | (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. |
| 2 | Common | Common Stock, $0.10 par value | 2023-12-02 | F | D | 274 | $50.10 | 6,926 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of awards. |
| 3 | Derivative | Restricted Stock Units | 2023-12-02 | M | D | 616 | $0.00 | 0 | D | — · — to 2023-12-02 | 616 Common Stock, $0.10 par value | (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020. |